MC

499.05

-0.27%↓

NDA.FI

11.82

+1.37%↑

DIM

202.2

+0.45%↑

MC

499.05

-0.27%↓

NDA.FI

11.82

+1.37%↑

DIM

202.2

+0.45%↑

MC

499.05

-0.27%↓

NDA.FI

11.82

+1.37%↑

DIM

202.2

+0.45%↑

MC

499.05

-0.27%↓

NDA.FI

11.82

+1.37%↑

DIM

202.2

+0.45%↑

MC

499.05

-0.27%↓

NDA.FI

11.82

+1.37%↑

DIM

202.2

+0.45%↑

Search

Eurazeo SE

Открыт

СекторФинансы

62.85 1.45

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

61.95

Макс.

63.45

Ключевые показатели

By Trading Economics

Доход

-105M

Продажи

104M

Дивидендная доходность

4.54

Рентабельность продаж

-100.723

Сотрудники

549

EBITDA

-51M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+64.74% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

4.54%

4.36%

Следующий отчет о доходах

24 июл. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4.1B

Предыдущая цена открытия

61.4

Предыдущая цена закрытия

62.85

Техническая оценка

By Trading Central

Уверенность

Strong Bullish Evidence

Eurazeo SE График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 сент. 2024 г., 06:28 UTC

Приобретения, слияния, поглощения

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Сравнение c конкурентами

Изменение цены

Eurazeo SE Прогноз

Целевая цена

By TipRanks

64.74% рост

Прогноз на 12 месяцев

Средняя 100 EUR  64.74%

Максимум 100 EUR

Минимум 100 EUR

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для Eurazeo SE на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

1 ratings

1

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

58.9 / N/AПоддержка и Сопротивление

Краткосрочная

Strong Bullish Evidence

Среднесрочная

Strong Bearish Evidence

Долгосрочная

Strong Bearish Evidence

Финансовые показатели

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil